Aura Biosciences, Inc., a clinical-stage biotech company that develops a new class of virus-like drug conjugate therapies for multiple cancer indications, announced that AU-011, the…
October 2, 2023
Aura Biosciences, Inc., a clinical-stage biotech company that develops a new class of virus-like drug conjugate therapies for multiple cancer indications, announced that AU-011, the…